Fundraising Fox
Ethypharm
Founded 1977 · 1,139 employees on LinkedIn · 1 known investors
Find your way into Ethypharm
Sign up to see every warm intro you have to Ethypharm
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ethypharm team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ethypharm is a specialty pharmaceutical company that develops and provides injectable medicines focused on Central Nervous System conditions including severe pain and addiction treatment, as well as critical care hospital injectables. The company serves patients and healthcare providers in hospital and emergency care settings.
Founders & leadership
DD
Denis DelvalPresident & CEODenis Delval is President and CEO of Ethypharm, a specialty pharmaceutical company developing injectable medicines for central nervous system conditions and critical care. He previously served as CEO of LFB, an international biopharma company focused on plasma derivatives, where he oversaw business restructuring, international expansion, and manufacturing improvements.
EC
Eric ChevalierChief People Officer
FR
Foucauld RuyantChief Financial OfficerHe previously held financial leadership roles in large regulated organizations, including managing a €900M business unit and directing financial planning and analysis for a €1.8B group, with expertise in financial transformation, consolidation, and working capital optimization.
CP
Cecile PaillousChief Scientific Affairs OfficerCecile Paillous holds an Industrial Pharmacist degree and an MBA-equivalent in Quality Management from ESC Paris. She has spent over 20 years at Ethypharm leading pharmaceutical quality systems, GMP compliance, and quality assurance operations, with prior experience as an ISO consultant in medical devices and pharmaceuticals.
XL
Xavier LasserreChief Commercial Operations OfficerXavier Lasserre is Chief Commercial Operations Officer at Ethypharm, a specialty pharmaceutical company developing injectable medicines for CNS conditions and critical care. He brings 25 years of healthcare industry experience across generics, OTC, and hospital business in European and emerging markets, with previous executive roles in operations, business transformation, and private equity-backed healthcare companies.
GM
Guilhem MaravalChief Operating OfficerGuilhem Maraval is Chief Operating Officer of Ethypharm, a European specialty pharmaceutical company that develops injectable medicines for central nervous system conditions, pain management, addiction treatment, and critical care applications distributed across more than 80 countries.
Investors · 1
Frequently asked questions
- What does Ethypharm do?
- Ethypharm is a specialty pharmaceutical company that develops and provides injectable medicines focused on Central Nervous System conditions including severe pain and addiction treatment, as well as critical care hospital injectables. The company serves patients and healthcare providers in hospital and emergency care settings.
- Who are Ethypharm's investors?
- Ethypharm's investors include Astorg.